Details of the Drug

General Information of Drug (ID: DMFJARS)

Drug Name
BXCL101
Indication
Disease Entry ICD 11 Status REF
Neurofibromatosis type 2 LD2D.11 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0AF8E

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)